Aurinia Pharma, Sun Pharma enter into settlement agreement for dry eye disease drug

The Canadian pharmaceuticals company said the settlement involves filing a joint motion with Sun Pharmaceutical to terminate an inter partes review of an Aurinia patent, as well as to settle patent infringement litigation in the U.S. over Sun Pharamceutical’s Cequa dry-eye treatment.